The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinases, on a subacute model of proliferative vitreoretinopathy

U. Ozerdem, B. Mach-Hofacre, L. Cheng, S. Chaidhawangul, K. Keefe, C. D. McDermott, G. Bergeron-Lynn, K. Appelt, W. R. Freeman

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)447-453
Number of pages7
JournalCurrent Eye Research
Volume20
Issue number6
DOIs
StatePublished - 2000
Externally publishedYes

ASJC Scopus Subject Areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Keywords

  • Matrix metalloproteinase inhibitors
  • Proliferative vitreoretinopathy
  • Treatment

Cite this